Stop and verify
A payment form is not a prescription. A coupon is not a prescription. A package label is not a prescription.
When tirzepatide offers unravel
Pause when the facts stay hidden
A single odd detail might have a fair explanation. A pattern of secrecy, urgency and impossible claims is a reason to step away.
RED FLAG SHEET
Pause.Check.Leave.
Prescription
“No prescription needed”
Federal law says a prescription medicine may only be handed over on a valid prescription from a licensed professional allowed to prescribe, such as a doctor.
A site offering tirzepatide without a prescription is showing the clearest legal warning sign.
Source: federal prescription lawAssessment
A menu, a fixed form and an instant yes
In the view of the Federation of State Medical Boards, the nationwide body of state medical boards, it is not proper care when a patient simply picks a medicine from a list with no real health check.
It also says a fixed online form is not enough on its own if nobody can ask follow-up questions or collect missing details.
State law varies, but speed alone is not proof of a sound visit.
Source: medical board guidanceLook for a real exchange
- A named, licensed clinician (the doctor or other prescriber)
- Questions that change with the answers
- Room to decline or change the plan
- A way to ask questions after the visit
Product claim
“FDA-approved compounded tirzepatide”
That phrase is false: compounded medicines are not FDA-approved.
Watch for two look-alike phrases: “FDA registered” only means a company has put itself on an FDA list. It does not mean FDA-approved, and federal rules say registration approves neither the company nor what it makes.
A compounded drug may fill a real patient need, but it must be described for what it is.
Source: federal registration ruleAnother false shortcut
An NDC number is an identifier in a drug directory. FDA says it does not show that the product is approved.
NDC means National Drug Code. It helps identify a listed drug product; it is not a quality score or an approval stamp.
Source
“Research use only” with human-use clues
FDA has warned sellers that “research use only” and “not for human consumption” do not erase evidence that a product is being sold for people.
Some sellers ship the vial with a bottle of water for turning the powder into an injection, a dosing chart, or claims about treating people. FDA treats those extras as signs the product is meant to be injected by people, which makes the problem clearer, not smaller.
Source: FDA enforcement letterNames that cannot be checked
Pause if the service will not name the prescriber or the pharmacy that fills the order. FDA has reported fraudulent tirzepatide labels naming pharmacies that were not real or that never made the product.
Delivery
A damaged package or a warm refrigerated product
FDA has received complaints about pharmacy-made GLP-1 shots, the family of weight and diabetes shots that includes tirzepatide, arriving warm or without enough cold packing.
FDA recommends not using an injectable GLP-1 product that arrives warm or without enough refrigeration because its quality can be affected.
Source: FDA delivery concernsKeep the package and label details. The pharmacy that sent it and the prescribing doctor need those details to investigate a problem.